NO970089L - Sulfonamidazolonderivater med anti-Helicobacteraktivitet - Google Patents

Sulfonamidazolonderivater med anti-Helicobacteraktivitet

Info

Publication number
NO970089L
NO970089L NO970089A NO970089A NO970089L NO 970089 L NO970089 L NO 970089L NO 970089 A NO970089 A NO 970089A NO 970089 A NO970089 A NO 970089A NO 970089 L NO970089 L NO 970089L
Authority
NO
Norway
Prior art keywords
formula
compounds
alkyl
compound
pharmaceutically acceptable
Prior art date
Application number
NO970089A
Other languages
English (en)
Norwegian (no)
Other versions
NO970089D0 (no
Inventor
Jan Heeres
Raymond Antoine Stokbroekx
Joseph Hector Mostmans
Louis Jozef Elisabeth Va Veken
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO970089D0 publication Critical patent/NO970089D0/no
Publication of NO970089L publication Critical patent/NO970089L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Lubricants (AREA)
NO970089A 1994-07-12 1997-01-09 Sulfonamidazolonderivater med anti-Helicobacteraktivitet NO970089L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202015 1994-07-12
PCT/EP1995/002619 WO1996001818A1 (en) 1994-07-12 1995-07-05 Sulfonamide derivatives of azolones anti-helicobacter agents

Publications (2)

Publication Number Publication Date
NO970089D0 NO970089D0 (no) 1997-01-09
NO970089L true NO970089L (no) 1997-03-10

Family

ID=8217029

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970089A NO970089L (no) 1994-07-12 1997-01-09 Sulfonamidazolonderivater med anti-Helicobacteraktivitet

Country Status (21)

Country Link
US (2) US5571811A (de)
EP (1) EP0770071B1 (de)
JP (1) JPH10502386A (de)
CN (1) CN1068878C (de)
AT (1) ATE206706T1 (de)
AU (1) AU684981B2 (de)
BR (1) BR9508376A (de)
CA (1) CA2194562A1 (de)
CZ (1) CZ2997A3 (de)
DE (1) DE69523159T2 (de)
FI (1) FI970113A0 (de)
HU (1) HUT76636A (de)
IL (1) IL114537A (de)
MX (1) MX9700340A (de)
NO (1) NO970089L (de)
NZ (1) NZ289853A (de)
PL (1) PL318149A1 (de)
SK (1) SK4497A3 (de)
TW (1) TW341571B (de)
WO (1) WO1996001818A1 (de)
ZA (1) ZA955760B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
US5637592A (en) * 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones
CN1262281C (zh) 1999-03-17 2006-07-05 森永制果株式会社 含有可可组分的药品、饮食品和饲料
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US20050119251A1 (en) * 2001-12-21 2005-06-02 Jian-Min Fu Nicotinamide derivatives and their use as therapeutic agents
CA2505409C (en) * 2002-11-14 2017-04-04 Intercytex Limited Cultivation of hair inductive cells
AU2004221812B2 (en) * 2003-03-19 2010-02-18 Exelixis Inc. Tie-2 modulators and methods of use
EP2269610A3 (de) 2004-09-20 2011-03-09 Xenon Pharmaceuticals Inc. Heterozyklische Derivate und ihre Verwendung als Stearoyl-Coa-Desaturase-Inhibitoren
US20080167321A1 (en) * 2004-09-20 2008-07-10 Xenon Pharmaceuticals Inc. Pyridine Derivatives For Inhibiting Human Stearoyl-Coa-Desaturase
JP4958786B2 (ja) 2004-09-20 2012-06-20 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環誘導体および治療薬としてのそれらの使用
EP1799667B1 (de) * 2004-09-20 2013-03-20 Xenon Pharmaceuticals Inc. Heterozyklische derivate und ihre verwendung als therapeutische wirkstoffe
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
MX2007003319A (es) * 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
EP2289510A1 (de) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterozyklische Derivate zur Behandlung von durch Stearoyl-Coa-Desaturase-Enzyme verursachten Krankheiten
MX2007003327A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa.
US7547698B2 (en) * 2004-09-20 2009-06-16 Xenon Pharmaceuticals Inc. Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
EP3906226A4 (de) * 2019-01-06 2023-03-15 Psomagen, Inc. Htra-inhibitoren und caga-inhibitoren und deren verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
CA2076257A1 (en) * 1991-09-13 1993-03-14 Jan Heeres 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones

Also Published As

Publication number Publication date
CN1068878C (zh) 2001-07-25
FI970113A7 (fi) 1997-01-10
WO1996001818A1 (en) 1996-01-25
ZA955760B (en) 1997-01-13
MX9700340A (es) 1997-05-31
EP0770071B1 (de) 2001-10-10
HUT76636A (en) 1997-10-28
TW341571B (en) 1998-10-01
ATE206706T1 (de) 2001-10-15
US5571811A (en) 1996-11-05
PL318149A1 (en) 1997-05-12
DE69523159D1 (de) 2001-11-15
BR9508376A (pt) 1997-10-28
NZ289853A (en) 1997-11-24
FI970113L (fi) 1997-01-10
AU684981B2 (en) 1998-01-08
US5728700A (en) 1998-03-17
SK4497A3 (en) 1997-12-10
CZ2997A3 (en) 1997-09-17
NO970089D0 (no) 1997-01-09
CA2194562A1 (en) 1996-01-25
DE69523159T2 (de) 2002-06-20
EP0770071A1 (de) 1997-05-02
CN1152308A (zh) 1997-06-18
FI970113A0 (fi) 1997-01-10
IL114537A (en) 1999-04-11
IL114537A0 (en) 1995-11-27
HU9700080D0 (en) 1997-02-28
AU2981995A (en) 1996-02-09
JPH10502386A (ja) 1998-03-03

Similar Documents

Publication Publication Date Title
US5571811A (en) Sulfonamide derivatives of azolones
NO310290B1 (no) Acylazolonderivater med anti-Helicobacteraktivitet
NO970087L (no) Urea- og tiourea-azolonderivater med anti-Helicobacteraktivitet
NO310289B1 (no) Heterocykliske azolonderivater med anti-Helicobacteraktivitet
EP0754180B1 (de) Anti-helicobacter ester- oder carbamatderivate von azolonen
EP0770072A1 (de) Anti-helicobacter harnstoff-oder thioharnstoffderivate von azolonen
MXPA96004610A (en) Ester derivatives and anti-helicobac azolone carbamate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application